ASML vs TSLA: Which Is the Better Buy?

Side-by-side comparison of ASML Holding N.V. and Tesla, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-22.
ASML Holding N.V. Β· Technology
$1,458.97
+65.1% upside to fair value
Grade B High Quality
VS
Tesla, Inc. Β· Consumer Cyclical
$343.23
-5.3% upside to fair value
Low Conviction Grade D
QuantHub Verdict
ASML has more upside to fair value (+65.1%). ASML trades at a lower forward P/E (48.3x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric ASML TSLA
Current Price $1,458.97 $343.23
Fair Value Estimate $2,408.73 $325.00
Upside to Fair Value +65.1% -5.3%
Market Cap $562.3B $1,287.9B
Forward P/E 48.3x 205.5x
EV / EBITDA 37.6x 108.8x
Price / Sales 14.4x 13.6x
Price / FCF 54.4x 207.1x
Revenue Growth YoY +13.2% -2.9%
Gross Margin 52.6% 18.0%
Operating Margin 34.8% 4.6%
Return on Equity 52.0% 4.8%
Dividend Yield 0% 0%
FCF Yield 1.84% 0.48%
Analyst Consensus Strong Buy β€”
Investment Thesis
ASML β€” ASML Holding N.V.
ASML Holding N.V. is a leading technology company specializing in semiconductor manufacturing equipment, particularly extreme ultraviolet lithography machines which hold a near-monopoly position. The company benefits from a durable competitive moat driven by its technological leadership, high barriers to entry, and strong demand from semiconductor manufacturers globally, especially in China. Desp…
TSLA β€” Tesla, Inc.
Tesla remains the most polarizing stock in markets. The core auto business is deteriorating: FY2025 revenue fell 2.9% to $94.8B, net income dropped 46.8% to $3.8B, and Q4 deliveries declined 15.6% YoY to 418K units. Yet the stock trades at 13.6x TTM P/S (near 5yr highs) on the optionality of Cybercab robotaxis launching April 2026, FSD reaching unsupervised status in Austin, and Optimus humanoid …
Accumulation Zones
Metric ASML TSLA
Zone Low $1,806.55 $244.00
Zone High $2,047.42 $276.00
In Buy Zone? Yes No
← ASML Research    TSLA Research β†’    All Research